Effectiveness of an Embedded Infectious Disease Screening, Treatment, and Prevention Intervention Within an Inpatient Substance Use Treatment Program - Summary - MDSpire
Advertisement
Effectiveness of an Embedded Infectious Disease Screening, Treatment, and Prevention Intervention Within an Inpatient Substance Use Treatment Program
To evaluate the effectiveness of comprehensive infectious disease (ID) screening integrated within an inpatient substance use disorder (SUD) treatment program, addressing barriers to care.
Key Findings:
Screening for ≥1 ID increased from 60.2% in usual care to 90.8% in the intervention group (P < .001).
Vaccination rates for HAV and HBV rose significantly from 0% to 58% and 71%, respectively.
36.8% of patients in the intervention group initiated direct-acting antiviral therapy for HCV within 2 weeks of testing, compared to 0% in usual care.
STIs were identified in 13.5% of the intervention group versus 9.2% in usual care (P = .09), indicating a trend towards increased identification.
Interpretation:
Integrating comprehensive ID screening within inpatient SUD programs significantly enhances testing uptake and facilitates timely preventive and therapeutic interventions.
Limitations:
The study was conducted at a single site, which may limit generalizability.
Only the first hospitalization was included for patients with multiple admissions, potentially affecting the data.
Lack of long-term follow-up data on patient outcomes.
Conclusion:
Comprehensive ID screening within inpatient SUD programs can effectively increase testing rates and improve access to preventive and therapeutic care for infectious diseases, suggesting a need for further research in diverse settings.
by Kelly E Dyer, Rebecca Russell, Rayek Nafiz, Angela Burdick-McPhee, Jean O’Neal, Tanajsia Mason, Danica Kuncio, Hannah Zellman, Margaret Lowenstein, Nancy Aitcheson, Vincent Lo Re, Jessie Torgersen
